# NATIONAL MARROW DONOR PROGRAM: Clinical and mechanistic studies defining optimal preparative approaches to infants with IL2RG/JAK3/RAG1/RAG2 SCID: a randomized trial of busulfan dosage

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | NATIONAL MARROW DONOR PROGRAM |
| Location | MINNEAPOLIS, MN |
| Project | Clinical and mechanistic studies defining optimal preparative approaches to infants with IL2RG/JAK3/RAG1/RAG2 SCID: a randomized trial of busulfan dosage |
| Project number | 3U01AI184132-03S1 |
| Mechanism | U01 |
| Institute | National Institute of Allergy and Infectious Diseases |
| Award | $111,904 |
| Awarded | 2026-08-27 |
| Project period | 2024-08-13 to 2029-05-31 |
| UEI | FR89NXNNSDX3 |

## Why this score
- Award of $111,904.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11555650). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.